Although its applicability in humans has to be still assessed, in vitro and vivo studies showed that it induces a growth defect in human cancer cell lines, leads to a significant decrease in growth rates in xenograft tumors and shows a potent inhibition of NQO1 in most tissues of mice (43, 44, 48). Here, NQO1 is linked to cancer.